ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.676,86
-0,48%
S&P 500
5.308,13
0,09%
Dow Jones
39.806,77
-0,49%
Euro vs US Dollar
1,08681
0,07%
Bitcoin
71.016,96
-0,61%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. BioCardia Inc (BCDA)

  7. BioCardia Inc (BCDA) News

BCDA

BioCardia (BCDA)

BioCardia Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:BCDA
DatumZeitQuelleÜberschriftSymbolFirma
14/05/202422h02GlobeNewswire Inc.BioCardia Reports First Quarter 2024 Business Highlights and Financial ResultsNASDAQ:BCDABioCardia Inc
01/05/202413h00GlobeNewswire Inc.BioCardia’s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important OutcomesNASDAQ:BCDABioCardia Inc
25/04/202415h00GlobeNewswire Inc.BioCardia Completes Enrollment of CardiAMP Cell Therapy for the Treatment of Chronic Myocardial Ischemia Trial Open Label Roll-In CohortNASDAQ:BCDABioCardia Inc
27/03/202421h00GlobeNewswire Inc.BioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial ResultsNASDAQ:BCDABioCardia Inc
20/03/202412h00GlobeNewswire Inc.BioCardia to Host 2023 Financial Results and Corporate Update Conference Call on March 27, 2024NASDAQ:BCDABioCardia Inc
13/03/202412h00GlobeNewswire Inc.BioCardia and StemCardia Announce Biotherapeutic Delivery PartnershipNASDAQ:BCDABioCardia Inc
12/03/202412h00GlobeNewswire Inc.BioCardia Announces CMS Approval of Coverage for CardiAMP Cell Therapy Confirmatory Phase III Heart Failure StudyNASDAQ:BCDABioCardia Inc
04/03/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCDABioCardia Inc
04/03/202414h00GlobeNewswire Inc.BioCardia Reports Positive Interim Results from Phase III CardiAMP Cell Therapy Heart Failure Trial, with Compelling Data in Subgroup with Elevated NTproBNP Biomarker for Heart FailureNASDAQ:BCDABioCardia Inc
27/02/202422h53Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:BCDABioCardia Inc
15/02/202413h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCDABioCardia Inc
14/02/202423h06Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BCDABioCardia Inc
14/02/202422h17Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BCDABioCardia Inc
09/02/202415h58Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCDABioCardia Inc
08/02/202413h03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCDABioCardia Inc
08/02/202413h00GlobeNewswire Inc.BioCardia Announces Activation of CardiAMP Heart Failure II Phase 3 Pivotal Study Recently Approved by FDANASDAQ:BCDABioCardia Inc
06/02/202422h28Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:BCDABioCardia Inc
02/02/202420h06Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BCDABioCardia Inc
31/01/202413h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCDABioCardia Inc
31/01/202413h00GlobeNewswire Inc.BioCardia Announces Two Scientific Abstracts Have Been Accepted at the 2024 Technology and Heart Failure Therapeutics ConferenceNASDAQ:BCDABioCardia Inc
03/01/202413h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCDABioCardia Inc
03/01/202413h00GlobeNewswire Inc.BioCardia Biotherapeutic Delivery and Morph Access Innovations Business Development Update for ShareholdersNASDAQ:BCDABioCardia Inc
19/12/202313h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCDABioCardia Inc
19/12/202313h00GlobeNewswire Inc.BioCardia Doses First Patient in CardiALLO Phase I/II Clinical Trial of BCDA-03 Allogeneic Mesenchymal Stem Cells for the Treatment of Ischemic Heart Failure of Reduced Ejection FractionNASDAQ:BCDABioCardia Inc
18/12/202313h16GlobeNewswire Inc.BioCardia Announces Expected CardiAMP Heart Failure Japan Approval Timeline Based on Pharmaceutical and Medical Device Agency Consultation MinutesNASDAQ:BCDABioCardia Inc
18/12/202313h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCDABioCardia Inc
06/12/202312h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCDABioCardia Inc
06/12/202312h03Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BCDABioCardia Inc
06/12/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BCDABioCardia Inc
05/12/202322h11Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:BCDABioCardia Inc
 Showing the most relevant articles for your search:NASDAQ:BCDA

Kürzlich von Ihnen besucht

NASDAQ
MSFT
Microsoft
TG
MBG
MercedesBenz
TG
DTE
Deutsche Telekom
AMEX
XLE
Energy Select Sector SPDR
AMEX
SPY
SPDR S&P 500
TG
ALV
Allianz
DBI
SDXP
SDAX
CCOM
US100
US Tech 100
NYSE
DIS
Walt Disney
TG
NOV
Novo Nordisk
NASDAQ
NVDA
NVIDIA
DBI
MDAX
MDAX
COIN
BTCUSD
Bitcoin
USOTC
ADDYY
Adidas (QX)
USOTC
BNPQY
BNP Paribas (QX)
FX
EURUSD
Euro vs US Dollar
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten